Metis Global Partners LLC Has $3.78 Million Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Metis Global Partners LLC boosted its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 6.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 186,503 shares of the real estate investment trust’s stock after acquiring an additional 11,363 shares during the quarter. Metis Global Partners LLC’s holdings in Healthpeak Properties were worth $3,780,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. HM Payson & Co. acquired a new stake in Healthpeak Properties in the third quarter valued at about $25,000. Avior Wealth Management LLC acquired a new stake in Healthpeak Properties in the third quarter valued at about $37,000. Groupama Asset Managment acquired a new stake in Healthpeak Properties in the third quarter valued at about $37,000. Capital Performance Advisors LLP acquired a new stake in Healthpeak Properties in the third quarter valued at about $42,000. Finally, Wiser Advisor Group LLC acquired a new stake in Healthpeak Properties in the third quarter valued at about $42,000. 93.57% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have commented on DOC shares. Mizuho dropped their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. Wedbush dropped their target price on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, February 14th. Robert W. Baird dropped their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Tuesday, February 11th. Scotiabank dropped their target price on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research report on Friday. Finally, Royal Bank of Canada increased their target price on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $23.92.

Healthpeak Properties Price Performance

Shares of DOC opened at $20.44 on Friday. Healthpeak Properties, Inc. has a 1 year low of $16.49 and a 1 year high of $23.26. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The company has a market capitalization of $14.30 billion, a price-to-earnings ratio of 58.39, a price-to-earnings-growth ratio of 2.17 and a beta of 1.15. The business has a 50-day moving average of $20.19 and a 200-day moving average of $21.35.

Healthpeak Properties Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were issued a $0.305 dividend. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a yield of 5.97%. The ex-dividend date of this dividend was Friday, February 14th. Healthpeak Properties’s payout ratio is presently 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.